Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions (Q28248318)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25238946%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

title

Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25238946%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25238946%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Johnathan M Lancaster

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25238946%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

C Bethan Powell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25238946%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Debra L Richardson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25238946%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

SGO Clinical Practice Committee

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25238946%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

language of work or name

English

0 references

publication date

17 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25238946%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25238946%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25238946%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

3-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25238946%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25238946%20AND%20SRC:MED&resulttype=core&format=json

Hereditary cancer predisposition syndromes

16 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

The role of genetic testing for cancer susceptibility in gynecologic practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Breast and ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Hereditary colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Identification of the breast cancer susceptibility gene BRCA2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

BRCA2 mutations in primary breast and ovarian cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Mutation of a mutL homolog in hereditary colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Cancer risk in Lynch Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Risks of Lynch syndrome cancers for MSH6 mutation carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Cancer risks and immunohistochemical profiles linked to the Danish MLH1 Lynch syndrome founder mutation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Cowden syndrome: a critical review of the clinical literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Cancer and Lhermitte-Duclos disease are common in Cowden syndrome patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Lifetime cancer risks in individuals with germline PTEN mutations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

A serine/threonine kinase gene defective in Peutz-Jeghers syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Germline mutations in RAD51D confer susceptibility to ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Germline RAD51C mutations confer susceptibility to ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Mutations in BRIP1 confer high risk of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Germ-line deletion in DICER1 revealed by a novel MLPA assay using synthetic oligonucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Ovarian small cell carcinoma of hypercalcemic type - evidence of germline origin and SMARCA4 gene inactivation. a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Direct-to-consumer personal genome testing and cancer risk prediction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Limited family structure and BRCA gene mutation status in single cases of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Modeling Genetic Risk of Breast Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Prophylactic Oophorectomy Reduces Breast Cancer Penetrance During Prospective, Long-Term Follow-Up ofBRCA1Mutation Carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

ACOG Practice Bulletin No. 147: Lynch syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Laws restricting health insurers' use of genetic information: impact on genetic discrimination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

Life insurance and breast cancer risk assessment: Adverse selection, genetic testing decisions, and discrimination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.09.009

10.1016/J.YGYNO.2014.09.009

7 January 2021

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

76

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25238946%20AND%20SRC:MED&resulttype=core&format=json

release_d4mtgajfozbabhl7fjtxoa6naq

16 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/d4mtgajfozbabhl7fjtxoa6naq

mapped directly with Wikidata item

24 November 2022

based on heuristic

76

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

2 references

76

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25238946%20AND%20SRC:MED&resulttype=core&format=json